Boehringer Ingelheim’s COPD and asthma inhalers are now …

Boehringer Ingelheim’s COPD And Asthma Inhalers Are Now …

2 weeks from now

Ridgefield, Conn., June 1, 2024 – Boehringer Ingelheim’s new program to cap out-of-pocket costs at $35 per month for eligible patientsi for the company’s inhalers is now available. With this …

boehringer-ingelheim.com

$35 Cap On COPD And Asthma Inhalers In Effect | RT

2 weeks from now

Jun 3, 2024  · Boehringer Ingelheim’s new program to cap out-of-pocket costs at $35 per month for eligible patients for the company’s inhalers is now available, according to the company. …

respiratory-therapy.com

Boehringer Ingelheim Caps Asthma, COPD Inhalers At $35 Per …

2 weeks from now

Jun 5, 2024  · Out-of-pocket costs for Boehringer Ingelheim asthma and chronic obstructive pulmonary disease (COPD) inhalers will be capped at $35 per month for eligible patients, …

pulmonologyadvisor.com

Boehringer Ingelheim's COPD And Asthma Inhalers Are Now …

2 weeks from now

RIDGEFIELD, Conn., June 1, 2024 /PRNewswire/ -- Boehringer Ingelheim's new program to cap out-of-pocket costs at $35 per month for eligible patients i for the company's inhalers is now …

prnewswire.com

These Inhalers No Longer Cost More Than $35 Per Month

2 weeks from now

Mar 26, 2024  · Amidst untenable drug prices, there's finally some good news: Several pharmaceutical companies are capping the out-of-pocket price of select inhalers at $35. …

verywellhealth.com

Boehringer Ingelheim's COPD And Asthma Inhalers Are Now …

2 weeks from now

Boehringer Ingelheim's new program to cap out-of-pocket costs at $35 per month for eligible patientsi for the company's inhalers is now available. With this program, patients who have had ...

yahoo.com

Boehringer Ingelheim Inhaler Cost Cap Program Launches - Drug …

2 weeks from now

Jun 3, 2024  · Article. All Boehringer Ingelheim inhalers are included in the program and will be available for $35 per month for eligible patients. A first of its kind program from Boehringer …

drugtopics.com

Patient Preferences For Inhaler Devices In Chronic Obstructive ...

2 weeks from now

Therapy with Respimat ® SMI was rated better or much better than therapy with the patient’s previous inhaler by 81% of patients, and 94.4% actually continued using Respimat ® SMI. 46 …

nih.gov

Boehringer Ingelheim Caps Patient Out-of-pocket Costs For Its …

2 weeks from now

Ridgefield, Conn., March 7, 2024 – Boehringer Ingelheim today announced it will cap out-of-pocket costs at $35 per month for eligible patients i for all the company’s inhaler products. …

boehringer-ingelheim.com